Roles of cytokines in the pathogenesis and therapy of type 1 diabetes

By Rabinovitch Alex   Suarez-Pinzon Wilma  

Cell Biochemistry and Biophysics, Vol. 48, Iss. 2-3, 2007-07 ,pp. : 159-163

Humana Press, Inc

Access to resources Recommend Favorite

Immune and cell therapy in type 1 diabetes: too little too late?

By Gillard Pieter   Mathieu Chantal  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 5, 2011-05 ,pp. : 609-621

Informa Healthcare

Access to resources Recommend Favorite

Treg in type 1 diabetes

By Brusko Todd   Atkinson Mark  

Cell Biochemistry and Biophysics, Vol. 48, Iss. 2-3, 2007-07 ,pp. : 165-175

Humana Press, Inc

Access to resources Recommend Favorite

DiaPep277 peptide therapy in the context of other immune intervention trials in type 1 diabetes

By Tuccinardi Dario   Fioriti Elvira   Manfrini Silvia   D'Amico Eugenio   Pozzilli Paolo  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 9, 2011-09 ,pp. : 1233-1240

Informa Healthcare

Access to resources Recommend Favorite

Protective effects of polyamine depletion in mouse models of type 1 diabetes: implications for therapy

By Tersey Sarah   Colvin Stephanie   Maier Bernhard   Mirmira Raghavendra  

Amino Acids, Vol. 46, Iss. 3, 2014-03 ,pp. : 633-642

Springer Publishing Company

Access to resources Recommend Favorite